Restorear Devices
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Restorear Devices sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Restorear Devices: 4 sponsored US clinical trials, 4 recruiting.
Restorear Devices sponsors 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting. The most-studied condition in this pipeline is Tinnitus, Subjective, with 2 trials.
Upper-quartile sponsor footprint
Restorear Devices sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Noninvasive Therapy for Tinnitus
NCT07071480
External Therapy for Tinnitus Management
NCT07017998
Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
NCT06729632
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
NCT06375278
Therapeutic Areas
What is open in the Restorear Devices pipeline
4 recruiting of 4 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Tinnitus, Subjective (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Restorear Devices: open-pipeline peers nationwide
Peers matched on 4 registered trials and 100% open enrollment, not the therapeutic-area sidebar.
Restorear Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 100% open enrollment (± trial volume)
- AAVantgarde Bio Srl · 100% recruiting · 2 trials
- Acorn Biolabs · 100% recruiting · 3 trials
- Acrivon Therapeutics · 100% recruiting · 2 trials
- ADARx Pharmaceuticals · 100% recruiting · 4 trials
Related
What to do with this Restorear Devices page
4 registered trials is a research-attention snapshot, not an endorsement of Restorear Devices or any single study.
- 4 of Restorear Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Tinnitus, Subjective is the condition Restorear Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Tinnitus, Subjective trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Restorear Devices pipeline card: 4 registered trials from official public datasets.Report a data error.